Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | CASP1 | P29466 | 1/20 | 0.42 |
| ▸ | CASP7 | P55210 | 1/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1054548 | 0.85 | MAOA (0.73) | MAOAALDH1A1TSHRMAPK1HSD17B10 | |
| SCHEMBL23972209 | 0.85 | MAOA (0.73) | MAOAALDH1A1TSHRMAPK1HSD17B10 | |
| SCHEMBL29644349 | 0.85 | MAOA (0.73) | MAOAALDH1A1TSHRMAPK1HSD17B10 | |
| SCHEMBL23972204 | 0.85 | MAOA (0.40) | MAOAALDH1A1TSHRMAPK1HSD17B10 | |
| Fluoranthene SCHEMBL11227281 | 0.84 | MAOA (0.71) | MAOAALDH1A1TSHRMAPK1HSD17B10 | |
| SCHEMBL23972195 | 0.81 | MAOA (0.52) | MAOAALDH1A1TSHRMAPK1HSD17B10 | |
| SCHEMBL22635014 | 0.80 | ALDH1A1 (0.58) | MAOAALDH1A1TSHRMAPK1HSD17B10 | |
| SCHEMBL23972192 | 0.78 | MAOA (0.49) | MAOAALDH1A1TSHRMAPK1HSD17B10 | |
| SCHEMBL23972190 | 0.78 | MAOA (0.39) | MAOA | |
| SCHEMBL21734473 | 0.75 | MAOA (0.49) | MAOAALDH1A1MAPK1HSD17B10HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12041845-B2 | Organic electroluminescent compound and organic electroluminescent device comprising the same | ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) | 2024-07-16 | — | — | US | disclosed |
| US-12041845-B2 | Organic electroluminescent compound and organic electroluminescent device comprising the same | ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) | 2024-07-16 | — | — | US | disclosed |
| US-20210343949-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | DUPONT SPECIALTY MATERIALS KOREA LTD (KR) | 2021-11-04 | — | — | US | disclosed |
| WO-2020036375-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) | 2020-02-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12041845-B2 | Organic electroluminescent compound and organic electroluminescent device comprising the same | L1CAM, OR10J3, EPCAM | MAOA 324/4885ALDH1A1 30/4885TSHR 3307/4885 |
| US-20210343949-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | L1CAM, OR10J3, EPCAM | MAOA 324/4885ALDH1A1 30/4885TSHR 3307/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.